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Introduction
FMF is the most common of the hereditary periodic fever
syndromes. It usually begins in the first two decades of
life, and as such, has a significant impact on women in
their reproductive years. To date, only one retrospective
study, investigating the course of FMF in pregnancy, has
been published.
Objectives
To examine the course of disease in FMF patients, while
pregnant, and to evaluate the association of pregnancy
with attack frequency and severity.
Methods
All pregnant FMF patients treated at the FMF clinic of the
Sheba Medical Center from May 2010 onwards, consent-
ing to participate in this observational study, were studied
prospectively for the occurrence of attacks. Attacks were
recorded by patients in diaries provided on enrollment
and relied by phone to a study coordinator on a monthly
telephone call or on a pre-specified physician visit, which-
ever occurred first. In addition to noting attack occur-
rence, patients were instructed to record attack severity
(on a 1-10 scale), attack location, duration, medications
taken during the attack, colchicine dose prior to and
during the attack, as well as ancillary signs and symptoms
related to their FMF such as the occurrence of exertional
leg pain.
Results
We present results of 28 pregnancies in 24 patients.
Average attack rate remained unchanged throughout the
pregnancy and the 9 month follow-up period post deliv-
ery (Average attack rates per 3 months, in the year before
pregnancy vs. 1st, 2nd and 3rd trimester of pregnancy as
well as the 9 months post delivery are 2.42 95%CI: 1.3-
6.1, 2.4 95%CI:0.8-4, 2.2 95%CI:0.9-2.5, 2.2 95%CI:1.1-4.3
and 1.94 95%CI 0.2-3.6, respectively).That being, an
amelioration in attack rate was experienced in 25% of the
pregnancies including 10.7% of pregnancies in which
attack rate decreased by more than 80% compared to the
pre-pregnancy value. Conversely, in 28.5% of pregnancies
patients experienced more frequent attacks. No signifi-
cant changes in attack severity or location, nor in colchi-
cine dose were noted. Early delivery was indicated
in about 10% of cases including a single patient with
pre-existing proteinuria, and increasing urinary protein
levels during the 3rd trimester. Pregnancy outcome was
favorable in all cases.
Conclusion
Pregnancy in FMF is safe for patients and their offspring.
Odds for amelioration, worsening or endurance of prior
course are similarly shared.
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